期刊文献+

连续性肾脏替代治疗在MICU危重患者中的应用 被引量:7

The application of contitunous renal replacement therapy in severe patients in MICU
下载PDF
导出
摘要 目的探讨连续性肾脏替代治疗(CRRT)在危重患者中的应用价值。方法选择内科重症监护室(MICU)实施CRRT治疗患者21例,均采用Prisma机器以及配套的管路和滤器,血管通路均采用股静脉或颈内静脉留置双腔导管,方式根据患者情况选择连续静脉血液滤过(CVVH)、连续静脉血液透析(CVVHD)、连续静脉血液透析滤过(CVVHDF),透析持续时间每日8~12小时,如病情需要则24小时持续进行,血流速100~150 ml/h,置换液30~50 L/次;每次脱水量根据病情设置1~3 kg。观察治疗前后临床症状,血流动力学,血生化,PaO2/FiO2,pH的变化及血培养结果。结果治疗后血培养转阴,血清尿素氮、肌酐值明显下降,氧合也有明显的改善。结论CRRT对于危重症患者来说是一个基本的治疗工具和重要的支持疗法。 Objective To investigate the practical value of continuous renal replacement therapy(CRRT) on the severe patients in MICU. Methods 21 cases who had applied to CRRT in MICU were selected. Double channel catheter was inserted in femoral vein or internal carotid vein,according to the pathogenetic condition. The patients were treated by Continuous Venovenous Hemofiltration (CVVH) Continuous Venoveneus Hemodialysis(CVVHD) and Continuous Venovenous Hemodiafihration ( CVVHDF). The duration was 8 - 12 hours or continuation if necessary. The volume of blood flow was 100 - 150 ml/h, and the displacement liquid was 30 - 50 ml/time. The volume of dehydration was 1 - 3 kg according to the pathogenetic condition. The clinical symptoms, hemodynamics, blood biochemistry, PaO2/ FiO2,pH, and hemocuhure before and after therapy were observed. Results After the treatment, the hemocuhure became minus, the serum creatinine and blood urea nitrogen decreased apparently, and oxygenation improved apparently. Conclusion To severe patients, CRRT is a basic treatment and an important supportive therapy.
出处 《临床肺科杂志》 2010年第5期627-628,共2页 Journal of Clinical Pulmonary Medicine
关键词 连续性肾脏替代治疗 多器官功能障碍综合征(MODS) continuous renal replacement therapy multiple organ dysfunction syndrome(MODS)
  • 相关文献

参考文献7

二级参考文献23

  • 1范连慧,吴雄飞,赵洪雯,余荣杰,干磊,刘宏,孙岩,金锡御.CRRT在顽固性频发心衰尿毒症患者肾移植中的应用[J].第三军医大学学报,2004,26(9):805-807. 被引量:18
  • 2叶任高 谢桐.急性肾功能衰竭诊断标准[J].新医学,1983,14:2-2.
  • 3Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23:1638- 1652.
  • 4Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occuring in the first 24 hrs in intensive care units in England, Wales, Northern Ireland. Crit Care Med, 2003, 31:2332-2338.
  • 5Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001, 29:1303-1310.
  • 6Weycker D, Akhras KS, Edelsberg J, et al. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med, 2003, 31:2316-2323.
  • 7Halonen KI, Pettila V, Leppaniemi AK, et al. Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med, 2002, 30:1274-1279.
  • 8Krishnan A, Karnad DR. Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med, 2003, 31: 2278-2284.
  • 9Richard S, Hotchkiss M. D, Irene E, et al. The pathophysiology and treatment of sepsis. New Engl J Med, 2003, 348:138
  • 10Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock, 1999, 11:153

共引文献178

同被引文献37

引证文献7

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部